Sleep and menopause

Nursing Clinics of North America

Volumn 39, Issue 1, 2004, Pages 97-115

  Landis, Carol A ^a   Moe, Karen E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR; BODY WEIGHT; BREATHING; DISEASE ASSOCIATION; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HEALTH; HEALTH STATUS; HOT FLUSH; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; LIMB MOVEMENT; MEDICAL EXAMINATION; MEDICAL LITERATURE; MEDICAL RESEARCH; MENOPAUSE; MOOD DISORDER; NEUROTRANSMISSION; NURSE ATTITUDE; OBESITY; PHYSIOLOGY; POLYSOMNOGRAPHY; POSTMENOPAUSE; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SEX RATIO; SEXUAL DEVELOPMENT; SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP STAGE; STRESS;

EID: 2442711782     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2003.11.006     Document Type: Review

References (117)

1. Akerstedt T, Knutsson A, Westerholm P, Theorell T, Alfredsson L, Kecklund G. Sleep disturbances, work stress and work hours: a cross-sectional study. J Psychosom Res 2002;53:741-8.
2. Shaver JLF. Women and sleep. Nurs Clin North Am 2002;37(4):707-18.
3. Woods NF. The menopausal transition: changing physiology, symptoms, and hormone therapy. In: Kaplan P, editor. Neurologic diseases in women. 2nd edition. New York: Demos; 2003.
4. McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res 2002;57:357-84.
5. Moline ML, Broch L, Zak R, Gross V. Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev 2003;7:155-77.
6. Epstein D, editor. Sleep and sleep disorders. Nurs Clin North Am 2002;37(4):583-731.
7. Webb WB, Agnew HW. Are we chronically sleep deprived? Bull Psychon Soc 1975;6:47-8.
8. Wehr TA, Moul DE, Barbato G, Giesen HA, Seidel JA, Barker C, et al. Conservation of photoperiod-responsive mechanisms in humans. Am J Physiol 1993;265:R846-57.
9. Johnson EO. 1998 Women and sleep poll. Washington (DC): National Sleep Foundation; 1998.
10. National Sleep Fountation. 2002 "Sleep in America" Poll. Executive summary. Available at: http://www.sleepfoundation.org. Accessed April 2, 2002.
11. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-6.
12. Wingard D, Berkman L. Mortality risk associated with sleeping patterns among adults. Sleep 1983;6:102-7.
13. Heslop P, Smith GD, Metcalfe C, Macleod J, Hart C. Sleep duration and mortality: the effect of short or long sleep duration and all-cause mortality in working men and women. Sleep Med 2002;3:305-14.
14. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003;163:205-9.
15. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diab Care 2003;26:380-4.
16. Belenky G, Wesensten NJ, Thorne DR, Thomas M, Sing HC, Redmond DP, et al. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res 2003;12:1-12.
17. Dinges DF, Pack F, Williams K, Gillen KA, Powell JW, Ott GE, et al. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep 1997;20:267-77.
18. Van Dongen HPA, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003;26:117-26.
19. Pilcher JJ, Huffcutt AI. effects of sleep deprivation on performance: a meta-analysis. Sleep 1996;19:318-26.
20. Spiegel K, Laproult R, Cauter EV. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-9.
21. Spiegel K, Sheridan JF, Cauter EV. effect of sleep deprivation on response to immunization. JAMA 2002;288:1471-2.
22. Mander B, Colecchia E, Spiegel K, Van Cauter E. Short sleep: a risk factor for insulin resistance and obesity. Sleep 2001;24:A74.
23. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88(6):2404-11.
24. Ford DE, Kramerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention. JAMA 1989;262:1479-84.
25. Ohayon MM, Caulet M, Philip P, Guilleminault C, Priest RG. How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med 1997;157:2645-52.
26. Bixler EO, Vgontzas AN, Lin H-M, Bela-Bueno A, Kales A. Insomnia in central Pennsylvania. J Psychosom Res 2002;53:589-92.
27. Hunter M, Battersby R, Whitehead M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas 1986;8:217-28.
28. Baker A, Simpson S, Dawson D. Sleep disruption and mood changes during menopause. J Psychosom Res 1997;43:359-69.
29. Owens JF, Matthews KA. Sleep disturbance in healthy middle-aged women. Maturitas 1998;30:41-50.
30. Jaszmann L, van Lith ND, Zaat JCA. The perimenopausal symptoms: the statistical analysis of a survey. Part A. Med Gynaec Sociol 1969;4:258-77.
31. Kuh DL, Wadsworth M, Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 1997;104:923-33.
32. Ballinger CB. Subjective sleep disturbance at the menopause. J Psychosom Res 1976;20:509-13.
33. Huerta R, Mena A, Malacara JM, de León JD. Symptoms at the menopausal and premenopausal years: their relationship with insulin, glucose, cortisol, FSH, prolactin, obesity and attitudes towards sexuality. Psychoneuroendocrinology 1995;20:851-64.
34. Shaver J, Giblin E, Lentz M, Lee K. Sleep patterns and stability in perimenopausal women. Sleep 1988;11:556-61.
35. Shaver JLF, Giblin E, Paulsen V. Sleep quality subtypes in midlife women. Sleep 1991;14:18-23.
36. Carskadon MA, Dement WC, Mitler MM, Guilleminault C, Zarcone VP, Spiegel R. Selfreports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia. Am J Psychiatry 1976;133:1382-8.
37. Vitiello MV, Larsen LH, Moe KE. Subjective-objective sleep relationships in noncomplaining healthy older men and women. J Psychosom Res, in press.
38. Vitiello MV. Sleep disorders and aging. Curr Opin Psychiatry 1996;9:284-9.
39. Middelkoop HA, Smilde van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol 1996;51A:M108-15.
40. Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL. Association of waking episode with menopausal hot flushes. JAMA 1981;245:1741-4.
41. Freedman RR, Roehrs TA. Menopausal sleep disturbance [abstract]. Sleep 2003;26(Suppl):A161.
42. Campbell S. Double blind psychometric studies on the effects of natural estrogens on post-menopausal women. In: Campbell S, editor. The management of the menopause and post-menopausal years. Baltimore (MD): University Park Press; 1976. p. 149-58.
43. Wiklund I, Karlberg J, Mattsson L-Å. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: A double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824-30.
44. Thomson J, Oswald I. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women. BMJ 1977;2:1317-9.
45. Scharf MB, McDannold MD, Stover R, Zaretsky N, Berkowitz DV. effects of estrogen replacement therapy on rates of cyclic alternating patterns and hot-flush events during sleep in postmenopausal women: a pilot study. Clin Ther 1997;19:304-11.
46. Schiff I, Regestein Q, Tulchinsky D, Ryan KJ. Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA 1979;242:2405-7.
47. Polo-Kantola P, Erkkola R, Helenius H, Irjala K, Polo O. When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol 1998;178:1002-9.
48. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, et al. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol 2002;100:1209-18.
49. Rodstrom K, Bengtsson C, Lissner L. A longitudinal study of the treatment of hot flushes. Menopause 2002;9:156-61.
50. Hicks RA, Garcia ER. Level of stress and sleep duration. Percept Mot Skills 1987;64:44-6.
51. Weller L, Avinir O. Hassles, uplifts, and quality of sleep. Percept Mot Skills 1993;76:571-6.
52. Cluydts R, Visser P. Mood and sleep. II. Effects of aversive pre-sleep stimulation. Waking Sleeping 1980;4:199-203.
53. Koulack D, Prevost F, DeKoninck J. Sleep, dreaming and adaptation to a stressful intellectual activity. Sleep 1985;8:244-53.
54. Shaver JLF, Johnston SK, Lentz MJ, Landis CA. Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia. Psychosom Med 2002;64:793-802.
55. Saab PG, Matthews KA, Stoney CM, McDonald RH. Premenopausal women and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. Psychophysiology 1989;26:270-80.
56. Lindheim SR, Legro RS, Berstein L, Stanczyk FZ, Vijod MA, Presser SC, et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol 1992;167:1831-6.
57. Moe KE, Larsen LH, Vitiello MV, Prinz PN. Estrogen replacement therapy moderates the sleep disruption associated with nocturnal blood sampling. Sleep 2001;24:886-94.
58. Vitiello MV, Larsen LH, Moe KE, Borson S, Schwartz RS, Prinz PN. Objective sleep quality of healthy older men and women is differentially disrupted by nighttime periodic blood sampling via indwelling catheter. Sleep 1996;19:304-11.
59. Riemann D, Berger M, Voderholzer U. Sleep and depression - results from psychobiological studies: an overview. Biol Psychiatry 2001;57:67-103.
60. Woods NF, Mariella A, Mitchell ES. Patterns of depressed mood across the menopausal transition: approaches to studying patterns of longitudinal data. Acta Obstet Gynecol Scand 2002;81:623-32.
61. Birkhäuser M. Depression, menopause and estrogens: is there a correlation? Maturitas 2002;41(Suppl 1):S3-8.
62. Manber R, Armitage R. Sex, steroids, and sleep: a review. Sleep 1999;22:540-55.
63. Joffe H, Hall JE, Soares CN, Hennen J, Reilly CJ, Carlson K, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-8.
64. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA, for the HERS Research Group. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy. Results from the Heart and Estrogen/Progestin Replacement Study (HERS) Trial. JAMA 2002;287:591-7.
65. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitundinal epidemiological study of young adults. Biol Psychiatry 1996;39:411-8.
66. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997;??:245-50.
67. Parker KP, Rye DB. Restless legs syndrome and periodic limb movement disorder. Nurs Clin North Am 2002;37:655-73.
68. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41.
69. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Gerger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Neurology 2000;54:1064-8.
70. Block AJ, Boysen PG, Wynne JW, Hunt LA. Sleep apnea, hypopnea and oxygen desaturation in normal subjects. N Engl J Med 1979;300:513-7.
71. Redline S, Kump K, Tishler PV, Browner I, Ferrette V. Gender differences in sleep disordered breathing in a community-based sample. Am J Respir Crit Care Med 1994;149:722-6.
72. Carskadon MA, Bearpark HM, Sharkey KM, Millman RP, Rosenberg C, Cavallo A, et al. effects of menopause and nasal occlusion on breathing during sleep. Am J Respir Crit Care Med 1997;155:205-10.
73. Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DL, Mason WJ, Mullaney DJ. Prevalence of sleep-disordered breathing in ages 40-64 yr: a population-based survey. Sleep 1997;20:65-76.
74. Guilleminault C, Soohs R, Kim Y-D, Chervin R, Black J, Clerk A. Upper airway sleepdisordered breathing in women. Ann Intern Med 1995;122:493-501.
75. Bixler EO, Vgontzas AN, Lin H-M, Have TT, Rein J, Vela-Bueno A, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001;163:608-13.
76. Young T, Finn L, Austin D, Peterson A. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003;167:1181-5.
77. Guilleminault C, Palombini L, Poyares D, Chowdhuri S. Chronic insomnia, postmenopausal women, and sleep disordered breathing. Part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res 2002;53:611-5.
78. Polo-Kantola P, Rauhala E, Saarestanta T, Aittokallio T, Erkkola R, Polo O. Climacteric vasomotor symptoms do not predict nocturnal breathing abnormalities in postmenopausal women. Maturitas 2001;39:29-37.
79. Baldwin CM, Quan MD. Sleep disordered breathing. Nurs Clin North Am 2002;37:633-54.
80. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-21.
81. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 2003;254:32-44.
82. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 2002;155:387-93.
83. Skatrud J, Dempsey J, Kaiser D. Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. J Appl Physiol 1978;44:939-44.
84. Regensteiner JG, Woodward WD, Hagerman DD, Weil JV, Pickett CK, Bender PR, et al. Combined effects of female hormones and metabolic rate on ventilatory drives in women. J Appl Physiol 1989;66:808-13.
85. Cook WR, Benich JJ, Wooten SA. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989;92:262-6.
86. Rajagopal KR, Abbrecht PH, Jabbari B. effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986;90:815-21.
87. Orr WC, Imes NK, Martin RJ. Progesterone therapy in obese patients with sleep apnea. Arch Intern Med 1979;139:109-11.
88. Strohl KP, Hensley MJ, Saunders NA, Scharf SM, Brown R, Ingram RHJ. Progesterone administration and progressive sleep apneas. JAMA 1981;245:1230-2.
89. Shahar E, Redline S, Young T, Boland LL, Baldwin CM, Nieto FJ, et al, for the Sleep Heart Health Study Research Group. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003;167:1186-92.
90. Pickett CK, Regensteiner JG, Woodard WD, Hagerman DD, Weil JV, Moore LG. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989;66:1656-61.
91. Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999;6:196-200.
92. Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003;26:163-8.
93. Cistulli PA, Barnes DJ, Grunstein RR, Sullivan CE. effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994;49:699-702.
94. Roberts CR, Rains JK, Pare PD, Walker DC, Wiggs B, Bert JL. Ultrastructure and tensile properties of human tracheal cartilage. J Biomech 1998;31:81-6.
95. Galconer C, Ekman-Orderberg G, Ulmsten U, Westergrem-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 1996;24:197-204.
96. Falconer C, Ekman G, Malmstrom A, Ulmsten U. Decreased collagen synthesis in stressincontinent women. Obstet Gynecol 1994;84:583-6.
97. Polo-Kantola P, Erkkola R, Irjala K, Pullinen S, Virtanen I, Polo O. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 1999;71:873-80.
98. Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C. Bevilacqua, Genazzani AR. Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas 2003;44:157-63.
99. Purdie DW, Empson JAC, Crichton C, MacDonald L. Hormone replacement therapy, sleep quality and psychological well-being. Br J Obstet Gynaecol 1995;102:735-9.
100. Montplaisir J, Lorrain J, Denesle R, Petit D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause 2001;8:10-6.
101. Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R. Progesterone-induced changes in sleep in male subjects. Am J Physiol 1997;272:E885-91.
102. Wiedemann K, Lauer CJ, Hirschmann M, Knaudt K, Holsboer F. Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men. Am J Physiol Endocrinol Metab 1998;274:E139-45.
103. Arafat ES, Hargrove JT, Maxson WS, Desiderio DM,Wentz AC, Andersen RN. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am J Obstet Gynecol 1988;159:1203-9.
104. de Lignières B, Vincens M. Differential effects of exogenous oestradiol and progesterone on mood in post-menopausal women: individual dose/effects relationship. Maturitas 1982;4:67-72.
105. de Lignières B. Oral micronized progesterone. Clin Ther 1999;21:41-60.
106. Fitzpatrick LA, Good A. Micronized progesterone: clinical indications and comparison with current treatments. Fertil Steril 1999;72:389-97.
107. Brooks EM, Morgan AL, Pierzga JM, Wladkowski SL, O'Gorman JT, Derr JA, et al. Chronic hormone replacement therapy alters thermoregulatory and vasomotor function in postmenopausal women. J Appl Physiol 1997;83:477-84.
108. Tankersley CG, Nicholas WC, Deaver DR, Mikita D, Kenney WL. Estrogen replacement in middle-aged women: thermoregulatory response to exercise in the heat. J Appl Physiol 1992;73:1238-45.
109. Cagnacci A, Melis GB, Soldani R, Paoletti AM, Fioretti P. Effect of sex steroids on body temperature in postmenopausal women. Role of endogenous opioids. Life Sci 1992;50:515-21.
110. Nakayama T, Suzuki M, Ishizuka N. Action of progesterone on preoptic thermosensitive neurones. Nature 1975;258:80.
111. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
112. Schumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, other WHIMS investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 2003;289:2651-62.
113. Simon JA, Mack CJ. Counseling patients who elect to discontinue hormone therapy. Int J Fertil Womens Med 2003;48:111-6.
114. Berg G, Gottqall T, Hammar M, Lindgren R. Climacteric symptoms among women aged 60-62 in Linköping, Sweden, in 1986. Maturitas 1988;10:193-9.
115. Hammar M, Ekblad S, Lönnberg B, Berg G, Lindgren R, Wyon Y. Postmenopausal women without previous or current vasomotor symptoms do not.ush after abruptly abandoning estrogen replacement therapy. Maturitas 1999;31:117-22.
116. Doughton S. Hormones worth the risk, some women say. Seattle Times, July 13, 2003.
117. The North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women. Position statement. Cleveland, OH; September 2003.